Department of Neurological Surgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA.
J Am Heart Assoc. 2012 Aug;1(4):e002865. doi: 10.1161/JAHA.112.002865. Epub 2012 Aug 24.
Small intracranial aneurysms pose significant challenges to endovascular therapy. Surgical clipping is considered by many to be the preferred treatment for these lesions. We present the results of the first study comparing the 2 treatment modalities in small ruptured aneurysms.
Between 2004 and 2011, 151 patients with small ruptured aneurysms (≤3 mm) were treated in our institution: 91 (60.3%) with endovascular therapy and 60 (39.7%) with surgical clipping. The surgical and endovascular groups were generally comparable with regard to baseline demographics, with the exception of larger mean aneurysm size in the endovascular group versus the surgical group (2.8 versus 2.5 mm, respectively; P<0.001) and a higher proportion of posterior circulation aneurysms in the endovascular group. Endovascular treatment failed in 9.9% of patients. Procedure-related complications occurred in 23.3% of surgical patients versus 9.8% of endovascular patients (P=0.01). Only 3.7% of patients undergoing endovascular therapy experienced an intraprocedural aneurysm rupture. There were no procedural deaths or rehemorrhages in either group. The rates of aneurysm recanalization and retreatment after endovascular therapy were 18.2% and 12.7%, respectively. Favorable outcomes (moderate, mild, or no disability) were not statistically different between the endovascular (67.1%) and surgical (56.7%) groups (P=0.3).
Surgical clipping was associated with a higher rate of periprocedural complications, but overall disability outcomes were similar. Endovascular therapy, if technically feasible, might be a preferred option in this setting. Inclusion of patients with small aneurysms in randomized controlled trials seems feasible and will be needed to provide definitive information on the best therapeutic approach. (J Am Heart Assoc. 2012;1:e002865 doi: 10.1161/JAHA.112.002865.).
小型颅内动脉瘤给血管内治疗带来了巨大的挑战。许多人认为手术夹闭是治疗这些病变的首选方法。我们报告了首例比较两种治疗方法治疗小型破裂动脉瘤的研究结果。
2004 年至 2011 年间,我院收治了 151 例小型破裂动脉瘤(≤3mm)患者:91 例行血管内治疗(60.3%),60 例行手术夹闭(39.7%)。手术组和血管内组在基线人口统计学方面基本可比,除血管内组动脉瘤平均直径大于手术组(分别为 2.8mm 和 2.5mm;P<0.001)和血管内组后循环动脉瘤比例较高外。血管内治疗失败率为 9.9%。手术组患者术中相关并发症发生率为 23.3%,血管内组为 9.8%(P=0.01)。仅有 3.7%的血管内治疗患者术中发生动脉瘤破裂。两组均无手术相关死亡或再出血。血管内治疗后动脉瘤再通和再治疗率分别为 18.2%和 12.7%。血管内组(67.1%)和手术组(56.7%)的患者预后良好(中度、轻度或无残疾)率无统计学差异(P=0.3)。
手术夹闭与更高的围手术期并发症发生率相关,但总体残疾结局相似。如果技术上可行,血管内治疗可能是该情况下的首选方法。纳入小型动脉瘤患者的随机对照试验似乎是可行的,需要这些试验提供关于最佳治疗方法的明确信息。